Welch & Forbes LLC Organon & Co. Transaction History

Welch & Forbes LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$31.66 - $38.9 $260,783 - $320,419	8,237 New	8,237 $278,000
Q4 2021 Jan 19, 2022	SELL	$28.67 - $37.13 $368,466 - $477,194	-12,852 Closed	0 $0
Q3 2021 Oct 13, 2021	SELL	$28.63 - $35.64 $532,861 - $663,331	-18,612 Reduced 59.15%	12,852 $422,000
Q2 2021 Jul 22, 2021	BUY	$28.45 - $38.0 $895,150 - $1.2 Million	31,464 New	31,464 $952,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

Stay updated on Welch & Forbes LLC with notifications on news.